查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1716381

透析設備市場預測至 2032 年：按產品類型、疾病類型、透析類型、最終用戶和地區進行的全球分析

Dialysis Equipment Market Forecasts to 2032 - Global Analysis By Product Type (Dialysis Machines, Dialyzers, Dialysis Concentrates, Bloodlines, Catheters and Other Product Types), Disease Type, Dialysis Type, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球透析設備市場預計在 2025 年達到 1,089 億美元，到 2032 年將達到 2,205 億美元，預測期內的複合年成長率為 10.6%。

透析設備由專門的醫療設備組成，當腎臟無法再有效地發揮這些功能時，用於過濾和清除血液中的廢物、多餘的液體和毒素。該設備對於患有慢性腎臟病和腎衰竭的患者來說必不可少。主要部件包括透析設備、透析器（人工腎臟）以及促進血液和透析液流動的管道系統。透析可以在醫療機構或家中進行。透析設備有助於維持體內化學平衡並支持整體健康。

根據美國腎臟基金會統計，3700萬美國人患有腎臟疾病。近808,000名美國人患有腎衰竭。超過 557,000 名美國人正在接受透析治療。腎臟疾病正以驚人的速度增加。

慢性腎臟病（CKD）和末期腎功能衰竭（ESRD）盛行率上升

慢性腎臟病(CKD) 和末期腎臟病 (ESRD) 盛行率的上升正在推動市場的成長。人口老化、糖尿病和高血壓盛行率上升以及久坐不動的生活方式等因素導致 CKD 和 ESRD 病例不斷增加。因此，對透析治療和相關設備的需求增加。這種不斷成長的需求正在推動技術進步，並增加全球對更有效率、更便利、以患者為中心的透析解決方案的投資。

限制性報銷政策

限制性報銷政策限制了患者獲得先進療法的機會，並對市場產生負面影響。缺乏保險覆蓋和低報銷率導致醫療保健提供者不願意採用更新、更昂貴的透析技術。這限制了技術創新並減緩了家庭透析治療系統的普及，尤其是在中低收入地區。患者面臨自付費用增加的問題，並且可能會遭遇延遲或不理想的照護。這可能會導致市場成長受阻以及腎臟病患者的健康狀況惡化。

家庭透析治療的偏好日益增加

人們對家庭透析治療的日益偏好正在對市場產生重大影響。由於家庭治療方便、靈活且能提高生活品質，越來越多的患者選擇家庭治療。自動腹膜透析 (APD) 和攜帶式血液透析機機等家庭透析治療系統的技術進步使得家庭治療更加方便和有效。此外，保險報銷政策和政府措施正在推動家庭透析治療的採用，進一步推動市場成長。

缺乏熟練的醫療保健專業人員

熟練醫療保健專業人員的短缺對市場構成了重大挑戰。全球腎臟病專家、透析護理師、技術人員和支援人員的短缺阻礙了透析中心的有效運作，尤其是在中低收入地區。這些勞動力缺口導致患者照護最佳化不佳、死亡率上升以及先進透析技術未充分利用。在印度等國家，腎臟病專家分佈不均和訓練機會有限加劇了這些問題，限制了許多患者獲得挽救生命的治療。

COVID-19的影響

COVID-19 疫情對市場產生了重大影響，最初導致患者照護和供應鏈中斷。由於醫院關閉和資源重新分配導致包括常規透析治療在內的選擇性治療被推遲，疫情初期對透析設備的需求下降。此外，供應鏈中斷和原料短缺也影響了製造能力。然而，疫情凸顯了對先進透析解決方案的需求，從而增加了對家庭透析治療技術和遠端醫療整合的投資。隨著醫療保健系統的適應，這些技術創新有望推動透析設備市場的長期成長。

預計透析設備部分將成為預測期內最大的部分。

由於慢性腎臟病率上升和腎臟治療需求增加，預計透析設備領域將在預測期內佔據最大的市場佔有率。可攜式和家用透析設備等技術進步透析設備提高患者的舒適度和可及性。此外，將人工智慧和數據分析整合到透析設備中以實現更好的監控和管理正在推動創新。老年人口的增加和醫療保健基礎設施的改善進一步促進了全球透析設備市場的擴張。

預計血液透析機領域在預測期內將達到最高複合年成長率

由於全球慢性腎臟病(CKD) 和末期腎功能衰竭(ESRD) 患病率不斷上升以及人口老化，預計血液透析機領域將在預測期內實現最高成長率。以提高安全性、縮短治療時間和改善患者治療效果為重點的技術進步是主要趨勢。家庭血液透析機需求的不斷成長和攜帶式設備的發展進一步推動了市場擴張。因此，血液透析機設備市場預計將持續成長。

比最大的地區

預計亞太地區將在預測期內佔據最大的市場佔有率。由於糖尿病和高血壓發生率上升，中國和印度等國家的腎臟問題盛行率尤其高。政府舉措和醫療保健基礎設施的改善進一步推動了市場擴張。可攜式和家用透析設備的開發等技術進步正在提高其可及性。然而，設備和治療成本高、缺乏意識以及熟練專業人員短缺等挑戰可能會阻礙某些地區的市場成長。

複合年成長率最高的地區：

在預測期內，由於慢性腎臟病盛行率的上升，預計北美將呈現最高的複合年成長率。注重家庭透析治療和使用者友善設備的技術進步是突出的趨勢。發達的醫療保健基礎設施和優惠的報銷政策也促進了市場的成長。然而，高昂的治療費用和長期透析相關的併發症風險仍然是個挑戰。人們對攜帶式和穿戴式透析設備的興趣日益濃厚，對治療腎臟疾病的遠端醫療的投資也在增加。

免費客製化服務

訂閱此報告的客戶可享有以下免費自訂選項之一：

  • 公司簡介
    • 對其他市場公司（最多 3 家公司）進行全面分析
    • 主要企業的SWOT分析（最多3家公司）
  • 地理細分
    • 根據客戶興趣對主要國家市場進行估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 研究範圍
  • 調查方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 研究途徑
  • 研究材料
    • 主要研究資料
    • 次級研究資訊來源
    • 先決條件

第3章市場走勢分析

  • 驅動程式
  • 限制因素
  • 機會
  • 威脅
  • 產品分析
  • 最終用戶分析
  • 新興市場
  • COVID-19的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買家的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球透析設備市場（依產品類型）

  • 透析設備
  • 透析器
  • 透析濃縮液
  • 血統
  • 導管
  • 其他產品類型

6. 全球透析設備市場（依疾病類型）

  • 慢性腎臟病（CKD）
  • 末期腎病（ESRD）
  • 急性腎損傷（AKI）
  • 多囊性腎病變（PKD）
  • 高血壓腎臟病
  • 糖尿病腎臟病
  • 其他類型的疾病

7. 全球透析設備市場（依透析類型）

  • 血液透析機
  • 腹膜透析

第8章全球透析設備市場（按最終用戶）

  • 醫院
  • 門診手術中心（ASC）
  • 透析中心
  • 診所
  • 居家照護
  • 其他最終用戶

9. 全球透析設備市場（按地區）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第10章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章 公司概況

  • Fresenius Medical Care
  • Baxter International Inc.
  • B. Braun Melsungen AG
  • Nipro Corporation
  • Nikkiso Co., Ltd.
  • Asahi Kasei Corporation
  • DaVita Inc.
  • Medtronic plc
  • Rockwell Medical Inc.
  • Becton Dickinson and Company
  • Dialife SA
  • Isopure Corp.
  • Quanta Dialysis Technologies Ltd.
  • NxStage Medical
  • Medivators Inc.
  • Allmed Medical Products Co., Ltd.
  • Atlantic Biomedical.
Product Code: SMRC29192

According to Stratistics MRC, the Global Dialysis Equipment Market is accounted for $108.9 billion in 2025 and is expected to reach $220.5 billion by 2032 growing at a CAGR of 10.6% during the forecast period. Dialysis equipment comprises specialized medical devices used to filter and remove waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. This equipment is essential for patients with chronic kidney disease or kidney failure. Key components include a dialysis machine, dialyzer (artificial kidney), and tubing system that facilitates the flow of blood and dialysate. The process can be performed in medical facilities or at home. Dialysis equipment helps maintain the body's chemical balance and supports overall health.

According to American Kidney Fund, up to 37 million Americans have kidney disease. Nearly 808,000 Americans are living with kidney failure. More than 557,000 Americans are on dialysis. Kidney disease is increasing at an alarming rate.

Market Dynamics:

Driver:

Rising Prevalence of Chronic Kidney Disease (CKD) and End-Stage Renal Disease (ESRD)

The rising prevalence of Chronic Kidney Disease (CKD) and End-Stage Renal Disease (ESRD) is fueling the growth of the market. Factors such as aging populations, increasing rates of diabetes and hypertension, and sedentary lifestyles contribute to the growing number of CKD and ESRD cases. As a result, there is a higher demand for dialysis treatment and related equipment. This surge is encouraging technological advancements and greater investments in more efficient, accessible, and patient-centric dialysis solutions worldwide.

Restraint:

Limited reimbursement policies

Limited reimbursement policies negatively impact the market by restricting patient access to advanced treatment options. Inadequate insurance coverage and low reimbursement rates discourage healthcare providers from adopting newer, more expensive dialysis technologies. This limits innovation and slows the adoption of home dialysis systems, especially in low- and middle-income regions. Patients may face increased out-of-pocket costs, leading to treatment delays or suboptimal care. Consequently, market growth is hindered, and health outcomes for individuals with kidney disease may worsen.

Opportunity:

Growing preference for home dialysis

The growing preference for home dialysis is significantly influencing the market. Patients are increasingly opting for home-based treatments due to their convenience, flexibility, and improved quality of life. Technological advancements in home dialysis systems, such as automated peritoneal dialysis (APD) and portable hemodialysis devices, have made at-home treatments more accessible and effective. Additionally, supportive reimbursement policies and government initiatives are encouraging the adoption of home dialysis, further driving market growth.

Threat:

Shortage of skilled healthcare professionals

The shortage of skilled healthcare professionals poses a significant challenge to the market. A global deficit in nephrologists, dialysis nurses, technicians, and support staff hampers the effective operation of dialysis centers, particularly in low- and middle-income regions. This workforce gap leads to suboptimal patient care, increased mortality rates, and underutilization of advanced dialysis technologies. In countries like India, the unequal distribution of nephrologists and limited training opportunities exacerbate these issues, limiting access to life-saving treatments for many patients.

Covid-19 Impact

The COVID-19 pandemic significantly impacted the market, initially causing disruptions in patient care and supply chains. Lockdowns and hospital resource reallocations led to postponed elective procedures, including routine dialysis treatments, resulting in decreased demand for dialysis equipment during the early stages of the pandemic. Additionally, supply chain interruptions and raw material shortages affected manufacturing capabilities. However, the pandemic also highlighted the need for advanced dialysis solutions, leading to increased investments in home dialysis technologies and telehealth integration. As healthcare systems adapt, these innovations are expected to drive long-term growth in the dialysis equipment market.

The dialysis machines segment is expected to be the largest during the forecast period

The dialysis machines segment is expected to account for the largest market share during the forecast period, due to the rising prevalence of chronic kidney diseases and the increasing demand for renal therapies. Technological advancements, such as portable and home-use dialysis machines, are enhancing patient comfort and accessibility. Additionally, the integration of artificial intelligence and data analytics in dialysis equipment for better monitoring and management is driving innovation. The growing elderly population and improved healthcare infrastructure are further contributing to the expansion of the dialysis machines market globally.

The hemodialysis segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the hemodialysis segment is predicted to witness the highest growth rate, driven by the rising global prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD), coupled with an aging population. Technological advancements focusing on enhanced safety, reduced treatment times, and improved patient outcomes are key trends. The increasing demand for home-based hemodialysis and the development of portable devices are further propelling market expansion. Consequently, the hemodialysis equipment market is expected to continue its upward trajectory in the coming years.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share. Countries like China and India are witnessing a particularly high prevalence of kidney disorders due to rising rates of diabetes and hypertension. Government initiatives and improving healthcare infrastructure are further boosting market expansion. Technological advancements, including the development of portable and home-based dialysis equipment, are enhancing accessibility. However, challenges such as the high cost of equipment and treatment, lack of awareness, and shortage of skilled professionals could potentially hinder market growth in some areas.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to rising prevalence of chronic kidney disease. Technological advancements focusing on home dialysis and user-friendly devices are prominent trends. A well-established healthcare infrastructure and favorable reimbursement policies further contribute to market growth. However, high treatment costs and the risk of complications associated with long-term dialysis remain challenges. The market is also witnessing a growing focus on portable and wearable dialysis devices and increasing investments in telehealth for kidney disease management.

Key players in the market

Some of the key players profiled in the Dialysis Equipment Market include Fresenius Medical Care, Baxter International Inc., B. Braun Melsungen AG, Nipro Corporation, Nikkiso Co., Ltd., Asahi Kasei Corporation, DaVita Inc., Medtronic plc, Rockwell Medical Inc., Becton Dickinson and Company, Dialife SA, Isopure Corp., Quanta Dialysis Technologies Ltd., NxStage Medical, Medivators Inc., Allmed Medical Products Co., Ltd. and Atlantic Biomedical.

Key Developments:

In January 2025, BD (Becton, Dickinson and Company), a leading global medical technology company, and Biosero, a developer of laboratory automation solutions to orchestrate scientific discoveries, today announced a framework collaboration agreement to enable and facilitate robotic arm integration with BD flow cytometry instruments to accelerate drug discovery and development.

In March 2024, AW Technologies and Asahi Kasei Medical, a core operating company of the Asahi Kasei Group, have entered into an exclusive distribution agreement in Japan for AW Technologies' TrachFlush(TM) device. Developed by AW Technologies based on an invention by an intensivist, the TrachFlush is a medical device to reduce the discomfort of ventilated patients while lightening the workload on healthcare professionals during tracheal suctioning.

Product Types Covered:

  • Dialysis Machines
  • Dialyzers
  • Dialysis Concentrates
  • Bloodlines
  • Catheters
  • Other Product Types

Disease Types Covered:

  • Chronic Kidney Disease (CKD)
  • End-Stage Renal Disease (ESRD)
  • Acute Kidney Injury (AKI)
  • Polycystic Kidney Disease (PKD)
  • Hypertensive Nephropathy
  • Diabetic Nephropathy
  • Other Disease Types

Dialysis Types Covered:

  • Hemodialysis
  • Peritoneal Dialysis

End Users Covered:

  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Dialysis Centers
  • Clinics
  • Home Care Settings
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Dialysis Equipment Market, By Product Type

  • 5.1 Introduction
  • 5.2 Dialysis Machines
  • 5.3 Dialyzers
  • 5.4 Dialysis Concentrates
  • 5.5 Bloodlines
  • 5.6 Catheters
  • 5.7 Other Product Types

6 Global Dialysis Equipment Market, By Disease Type

  • 6.1 Introduction
  • 6.2 Chronic Kidney Disease (CKD)
  • 6.3 End-Stage Renal Disease (ESRD)
  • 6.4 Acute Kidney Injury (AKI)
  • 6.5 Polycystic Kidney Disease (PKD)
  • 6.6 Hypertensive Nephropathy
  • 6.7 Diabetic Nephropathy
  • 6.8 Other Disease Types

7 Global Dialysis Equipment Market, By Dialysis Type

  • 7.1 Introduction
  • 7.2 Hemodialysis
  • 7.3 Peritoneal Dialysis

8 Global Dialysis Equipment Market, By End User

  • 8.1 Introduction
  • 8.2 Hospitals
  • 8.3 Ambulatory Surgical Centers (ASCs)
  • 8.4 Dialysis Centers
  • 8.5 Clinics
  • 8.6 Home Care Settings
  • 8.7 Other End Users

9 Global Dialysis Equipment Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Fresenius Medical Care
  • 11.2 Baxter International Inc.
  • 11.3 B. Braun Melsungen AG
  • 11.4 Nipro Corporation
  • 11.5 Nikkiso Co., Ltd.
  • 11.6 Asahi Kasei Corporation
  • 11.7 DaVita Inc.
  • 11.8 Medtronic plc
  • 11.9 Rockwell Medical Inc.
  • 11.10 Becton Dickinson and Company
  • 11.11 Dialife SA
  • 11.12 Isopure Corp.
  • 11.13 Quanta Dialysis Technologies Ltd.
  • 11.14 NxStage Medical
  • 11.15 Medivators Inc.
  • 11.16 Allmed Medical Products Co., Ltd.
  • 11.17 Atlantic Biomedical.

List of Tables

  • Table 1 Global Dialysis Equipment Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Dialysis Equipment Market Outlook, By Product Type (2024-2032) ($MN)
  • Table 3 Global Dialysis Equipment Market Outlook, By Dialysis Machines (2024-2032) ($MN)
  • Table 4 Global Dialysis Equipment Market Outlook, By Dialyzers (2024-2032) ($MN)
  • Table 5 Global Dialysis Equipment Market Outlook, By Dialysis Concentrates (2024-2032) ($MN)
  • Table 6 Global Dialysis Equipment Market Outlook, By Bloodlines (2024-2032) ($MN)
  • Table 7 Global Dialysis Equipment Market Outlook, By Catheters (2024-2032) ($MN)
  • Table 8 Global Dialysis Equipment Market Outlook, By Other Product Types (2024-2032) ($MN)
  • Table 9 Global Dialysis Equipment Market Outlook, By Disease Type (2024-2032) ($MN)
  • Table 10 Global Dialysis Equipment Market Outlook, By Chronic Kidney Disease (CKD) (2024-2032) ($MN)
  • Table 11 Global Dialysis Equipment Market Outlook, By End-Stage Renal Disease (ESRD) (2024-2032) ($MN)
  • Table 12 Global Dialysis Equipment Market Outlook, By Acute Kidney Injury (AKI) (2024-2032) ($MN)
  • Table 13 Global Dialysis Equipment Market Outlook, By Polycystic Kidney Disease (PKD) (2024-2032) ($MN)
  • Table 14 Global Dialysis Equipment Market Outlook, By Hypertensive Nephropathy (2024-2032) ($MN)
  • Table 15 Global Dialysis Equipment Market Outlook, By Diabetic Nephropathy (2024-2032) ($MN)
  • Table 16 Global Dialysis Equipment Market Outlook, By Other Disease Types (2024-2032) ($MN)
  • Table 17 Global Dialysis Equipment Market Outlook, By Dialysis Type (2024-2032) ($MN)
  • Table 18 Global Dialysis Equipment Market Outlook, By Hemodialysis (2024-2032) ($MN)
  • Table 19 Global Dialysis Equipment Market Outlook, By Peritoneal Dialysis (2024-2032) ($MN)
  • Table 20 Global Dialysis Equipment Market Outlook, By End User (2024-2032) ($MN)
  • Table 21 Global Dialysis Equipment Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 22 Global Dialysis Equipment Market Outlook, By Ambulatory Surgical Centers (ASCs) (2024-2032) ($MN)
  • Table 23 Global Dialysis Equipment Market Outlook, By Dialysis Centers (2024-2032) ($MN)
  • Table 24 Global Dialysis Equipment Market Outlook, By Clinics (2024-2032) ($MN)
  • Table 25 Global Dialysis Equipment Market Outlook, By Home Care Settings (2024-2032) ($MN)
  • Table 26 Global Dialysis Equipment Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.